Faheem Hasnain Insider Trading $KURA Kura Oncology, Inc.
Get free email notifications about insider trading for Faheem Hasnain.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Faheem Hasnain. Faheem Hasnain is EVP, Oncology/Rheumatology SBU in BIOGEN INC. ($IDPH) and SVP, Oncology SBU in BIOGEN INC. ($IDPH) and Director in VITAL THERAPIES INC ($VTL) and Director in Tocagen Inc ($TOCA) and Director in Kura Oncology, Inc. ($KURA) and President & CEO in Receptos, Inc. ($RCPT) and in Mirati Therapeutics, Inc. ($MYG) and Director in Gossamer Bio, Inc. ($GOSS) and Executive Chairman in Gossamer Bio, Inc. ($GOSS) and President & CEO in Gossamer Bio, Inc. ($GOSS) and Director in Nuvation Bio Inc. ($PANA).
Faheem Hasnain in Kura Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Faheem Hasnain: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 23 2021
$KURA Market Capitalization: $124.74M
$KURA Previous Close: $6.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Faheem Hasnain in Kura Oncology, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IDPH, TOCA, GOSS, VTL, KURA, MYG, NUVB, RCPT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2021 | KURA | Kura Oncology, Inc ... | Hasnain Faheem | Director | Option Exercise | A | 21.54 | 23,000 | 495,420 | 23,000 | |
| Jun 26 2020 | KURA | Kura Oncology, Inc ... | Hasnain Faheem | Director | Option Exercise | A | 17.97 | 23,000 | 413,310 | 23,000 | |
| Jun 27 2019 | KURA | Kura Oncology, Inc ... | Hasnain Faheem | Director | Option Exercise | A | 19.55 | 13,000 | 254,150 | 13,000 | |
| Jun 08 2018 | KURA | Kura Oncology, Inc ... | Hasnain Faheem | Director | Option Exercise | A | 16.35 | 13,000 | 212,550 | 13,000 | |
| Jun 12 2017 | KURA | Kura Oncology, Inc ... | Hasnain Faheem | Director | Option Exercise | A | 8.60 | 10,000 | 86,000 | 10,000 | |
| May 13 2016 | KURA | Kura Oncology, Inc ... | Hasnain Faheem | Director | Option Exercise | A | 3.12 | 10,000 | 31,200 | 10,000 | |
| Apr 27 2015 | KURA | Kura Oncology, Inc ... | Hasnain Faheem | Director | Option Exercise | A | 6.32 | 30,000 | 189,600 | 30,000 |
Page: 1